Bosman D K, Benninga M A, van de Berg P, Kooijman G C, van Gool T
Academisch Medisch Centrum/Universiteit van Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam.
Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):575-9.
To determine the effect of an antiprotozoic treatment on children with persistent abdominal pain and infection with Dientamoeba fragilis.
Retrospective.
A total of 43 children with D. fragilis infection and persistent gastrointestinal complaints were included in the study. Of these 27 were treated with clioquinol and 16 with a nitroimidazole drug: metronidazole or tinidazole. The parasitological and clinical effects of the treatment were assessed.
In 33 of the 43 (77%) children, no parasites were detected during follow-up with a triple faeces test: 22/27 following treatment with clioquinol and 11/16 following treatment with a nitroimidazole drug. In 27 of the 33 (82%) children with a negative follow-up result, gastrointestinal complaints were considerably less or had completely disappeared. In 2 of the 10 (20%) children in which D. fragilis had not disappeared in the follow-up period, the complaints were less or had disappeared.
Effective treatment of D. fragilis infection in children with longstanding gastrointestinal complaints often resulted in a reduction or disappearance of the complaints.
确定抗原生动物治疗对患有持续性腹痛且感染脆弱双核阿米巴的儿童的疗效。
回顾性研究。
共有43名感染脆弱双核阿米巴且有持续性胃肠道不适的儿童纳入本研究。其中27名接受氯碘羟喹治疗,16名接受硝基咪唑类药物(甲硝唑或替硝唑)治疗。评估治疗的寄生虫学和临床效果。
在43名儿童中的33名(77%),通过三次粪便检测在随访期间未检测到寄生虫:氯碘羟喹治疗后22/27例,硝基咪唑类药物治疗后11/16例。在随访结果为阴性的33名儿童中的27名(82%),胃肠道不适显著减轻或完全消失。在随访期间脆弱双核阿米巴未消失的10名儿童中的2名(20%),不适减轻或消失。
对患有长期胃肠道不适的儿童进行脆弱双核阿米巴感染的有效治疗通常会使不适减轻或消失。